Galleri is a blood test that looks for cancer-specific DNA methylation patterns and suggests a likely tissue of origin for 50 different types of cancer. It is offered as a complement to standard screening and is currently commercially available in the United States (list price: $949).
Author: Lidziya Tarasenka
Lidziya Tarasenka
Healthcare professional with a strong background in medical journalism, media redaction, and fact-checking healthcare information. Medical advisor skilled in research, content creation, and policy analysis. Expertise in identifying systemic healthcare issues, drafting reports, and ensuring the accuracy of medical content for public and professional audiences.
November’s agenda brings together policymakers, clinicians, and innovators in Madrid, Brussels, Strasbourg, and London for cross-sector discussions on resilience, AI, and translational science.
Some things come to stay. Podcasts manage this with almost nothing: a voice and a good question. No slides, no b-roll – just people who know their field thinking out loud. Here are five we actually learn from, not just listen to.
Do AI tools make clinicians better, or do they atrophy the very skills that keep patients safe?
The history of medicine contains many episodes of “redistribution” of skill. Each time, the practice reorganized and, overall, outcomes improved. Yet AI is definitely different from any instruments we’ve ever seen
Healthcare AI has attracted record investment and hype: by 2024, 78% of organizations reported using AI somewhere in their operations. What’s less clear is how much these deployments improve efficiency and productivity.
This conversation looks at a startup tackling a precise operational choke point: medication-adherence outreach in U.S. ambulatory care and pharmacy settings. Instead of promising to “fix the EMR,” Rivvi positions itself around the messy, human workflows that sit beside it – call lists, spreadsheets, payer feeds – and uses conversational AI to turn those inputs into structured, attributable actions.
We live in a world where data means a lot. But what if some of that data only creates the illusion of control, while actually making it harder to make decisions? This uncomfortable truth was explored in depth by Irina McLean, Health and Social Care Research Coordinator at NHS Research Scotland.
In 2022, 74.4% of U.S. physicians worked in practices that used telehealth, underscoring how routine virtual care has become. “No Access” – Medicare coverage at risk. Unless Congress acts, on Oct 1, 2025 Medicare’s pandemic-era flexibilities for non-behavioral telehealth from the home expire.
Like other sectors, healthcare is rapidly undergoing digital transformation. According to a forecast by Roland Berger, the global digital health market could grow to €1 trillion by 2026, with €59 billion projected in Germany. However, regardless of technological progress, digital innovations should prioritize empathy and compassion.
VIZZ eye drops improve vision within minutes. Mechanism, trials, and what to watch. FDA-approved aceclidine 1.44% eye drops to improve near vision in presbyopia. Once daily: 1 drop/eye, wait 2 min, then a 2nd drop from a single-use, preservative-free vial. Effect observed within ~30–180 min and measured up to 10 hours.